Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -259 | -98 | -60 | -80 | -189 |
| Depreciation Amortization | 16 | 8 | 26 | 18 | 12 |
| Accounts receivable | 551 | 644 | -701 | -2,079 | -6 |
| Accounts payable and accrued liabilities | -573 | -573 | 464 | 1,826 | 116 |
| Other Working Capital | -184 | 6 | -200 | -250 | 12 |
| Other Operating Activity | 30 | -66 | 255 | 265 | -102 |
| Operating Cash Flow | $-418 | $-79 | $-216 | $-301 | $-158 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -13 | -39 | -39 | -14 |
| Other Investing Activity | 3 | 1 | -9 | -11 | -8 |
| Investing Cash Flow | $-15 | $-12 | $-48 | $-49 | $-23 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 2,360 | 2,360 | 2,623 | 2,623 | 2,623 |
| End Cash Position | 1,926 | 2,269 | 2,360 | 2,273 | 2,442 |
| Net Cash Flow | $-433 | $-91 | $-264 | $-350 | $-181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -418 | -79 | -216 | -301 | -158 |
| Capital Expenditure | -18 | -13 | -39 | -39 | -14 |
| Free Cash Flow | -436 | -92 | -255 | -339 | -173 |